Thus, experimental design involving DNA damage response and apoptosis pathways in ESCC cell lines should be prudent, as canonical signaling pathways may be affected by dysfunctions of mutant p53 protein. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.